Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies

Detalles Bibliográficos
Autores principales: Langabeer, Stephen E., Haslam, Karl, Conneally, Eibhlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126362/
https://www.ncbi.nlm.nih.gov/pubmed/25152868
http://dx.doi.org/10.3389/fonc.2014.00212
_version_ 1782329891869425664
author Langabeer, Stephen E.
Haslam, Karl
Conneally, Eibhlin
author_facet Langabeer, Stephen E.
Haslam, Karl
Conneally, Eibhlin
author_sort Langabeer, Stephen E.
collection PubMed
description
format Online
Article
Text
id pubmed-4126362
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41263622014-08-22 Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies Langabeer, Stephen E. Haslam, Karl Conneally, Eibhlin Front Oncol Oncology Frontiers Media S.A. 2014-08-08 /pmc/articles/PMC4126362/ /pubmed/25152868 http://dx.doi.org/10.3389/fonc.2014.00212 Text en Copyright © 2014 Langabeer, Haslam and Conneally. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Langabeer, Stephen E.
Haslam, Karl
Conneally, Eibhlin
Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
title Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
title_full Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
title_fullStr Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
title_full_unstemmed Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
title_short Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
title_sort monitoring residual disease in the ph-negative myeloproliferative neoplasms post-allogeneic stem cell transplantation: more mutations and more methodologies
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126362/
https://www.ncbi.nlm.nih.gov/pubmed/25152868
http://dx.doi.org/10.3389/fonc.2014.00212
work_keys_str_mv AT langabeerstephene monitoringresidualdiseaseinthephnegativemyeloproliferativeneoplasmspostallogeneicstemcelltransplantationmoremutationsandmoremethodologies
AT haslamkarl monitoringresidualdiseaseinthephnegativemyeloproliferativeneoplasmspostallogeneicstemcelltransplantationmoremutationsandmoremethodologies
AT conneallyeibhlin monitoringresidualdiseaseinthephnegativemyeloproliferativeneoplasmspostallogeneicstemcelltransplantationmoremutationsandmoremethodologies

Ejemplares similares